Evidence map›Paper›PMID 33524049›Full record

ArticlePLoS genetics2021

Aberrant binding of mutant HSP47 affects posttranslational modification of type I collagen and leads to osteogenesis imperfecta.

Delfien Syx, Yoshihiro Ishikawa, Jan Gebauer, Sergei P Boudko, Brecht Guillemyn, Tim Van Damme, Sanne D'hondt, Sofie Symoens, Sheela Nampoothiri, Douglas B Gould and 3 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in PLoS genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. ER-resident proteins are key players in cartilage and bone homeostasis.Frontiers in cell and developmental biology · 2025
    Review
  8. Update on the Genetics of Osteogenesis Imperfecta.Calcified tissue international · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Delfien SyxCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0001-9421-4496
Yoshihiro IshikawaDepartment of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, Oregon, United States of America.ORCID 0000-0003-2013-0518
Jan GebauerInstitute of Biochemistry, University of Cologne, Cologne, Germany.ORCID 0000-0002-3989-4748
Sergei P BoudkoDepartment of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, Oregon, United States of America.ORCID 0000-0003-3856-4859
Brecht GuillemynCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0001-7194-6651
Tim Van DammeCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0002-6424-4421
Sanne D'hondtCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Sofie SymoensCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0003-4240-2772
Sheela NampoothiriAmrita Institute of Medical Sciences and Research Center, Cochin, Kerala, India.ORCID 0000-0002-9575-0722
Douglas B GouldDepartment of Ophthalmology, UCSF School of Medicine, San Francisco, California, United States of America.
Ulrich BaumannInstitute of Biochemistry, University of Cologne, Cologne, Germany.
Hans Peter BächingerDepartment of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, Oregon, United States of America.
Fransiska MalfaitCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Ghent University Hospital · BEOregon Health & Science University · USUniversity of Cologne · DEAmrita Institute of Medical Sciences and Research Centre · INUniversity of California, San Francisco · US

Funding

Genetic and Mechanistic Study of Cerebral Small Vessel DiseaseR01NS096173 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOULD, DOUGLAS · 2017 to 2021
$3.5M
NINDS NIH HHS R01 NS096173
6 · The paper itself

Abstract

Heat shock protein 47 (HSP47), encoded by the SERPINH1 gene, is a molecular chaperone essential for correct folding of collagens. We report a homozygous p.(R222S) substitution in HSP47 in a child with severe osteogenesis imperfecta leading to early demise. p.R222 is a highly conserved residue located within the collagen interacting surface of HSP47. Binding assays show a significantly reduced affinity of HSP47-R222S for type I collagen. This altered interaction leads to posttranslational overmodification of type I procollagen produced by dermal fibroblasts, with increased glycosylation and/or hydroxylation of lysine and proline residues as shown by mass spectrometry. Since we also observed a normal intracellular folding and secretion rate of type I procollagen, this overmodification cannot be explained by prolonged exposure of the procollagen molecules to the modifying hydroxyl- and glycosyltransferases, as is commonly observed in other types of OI. We found significant upregulation of several molecular chaperones and enzymes involved in procollagen modification and folding on Western blot and RT-qPCR. In addition, we showed that an imbalance in binding of HSP47-R222S to unfolded type I collagen chains in a gelatin sepharose pulldown assay results in increased binding of other chaperones and modifying enzymes. The elevated expression and binding of this molecular ensemble to type I procollagen suggests a compensatory mechanism for the aberrant binding of HSP47-R222S, eventually leading to overmodification of type I procollagen chains. Together, these results illustrate the importance of HSP47 for proper posttranslational modification and provide insights into the molecular pathomechanisms of the p.(R222S) alteration in HSP47, which leads to a severe OI phenotype.

Indexed as

Mutation, MissenseAmino Acid SequenceCells, CulturedChild, PreschoolCollagen Type IFatal OutcomeFemaleHSP47 Heat-Shock ProteinsHumansInfantInfant, NewbornModels, MolecularOsteogenesis ImperfectaProtein BindingProtein DomainsProtein Processing, Post-TranslationalCollagen Type IHSP47 Heat-Shock ProteinsRecombinant ProteinsSERPINH1 protein, human

Identifiers

PMID33524049
PMCPMC7877763
OpenAlexW3126936442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.